Fascin expression in CD30‐positive cutaneous lymphoproliferative disorders
- 1 May 2002
- journal article
- research article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 29 (5) , 295-300
Abstract
Background: CD30‐positive cutaneous lymphoproliferative disorders (LPD) represent a spectrum of diseases ranging from low‐grade (lymphomatoid papulosis; LyP) to high‐grade (pleomorphic and anaplastic large‐cell lymphoma; PTL, ALCL) with overlapping morphologic and immunophenotypic features. The common phenotypic hallmark is the expression of CD30‐antigen by the tumor cells which morphologically resemble Reed–Sternberg cells. Although LyP is a non‐fatal recurring disorder, it is associated with systemic lymphomas including Hodgkin's lymphoma (HL), mycosis fungoides (MF) and ALCL in 5–20% of the cases. Currently there is no marker to predict the development of systemic lymphomas in patients with LyP. Fascin, an actin bundling protein, has recently been shown to be a unique marker found in almost 100% of classical HL. Methods: Because of the association of LyP with HL, fascin expression was analyzed by immunohistochemistry in LyP (n = 45), cutaneous CD30+ ALCL (n = 17) and pleomorphic T‐cell lymphoma (n = 9) (PTL) and LyP associated with systemic lymphomas (7 HL, 2 ALCL, 1 MF), with the intent to determine if fascin expression can predict disease progression. Results: Fascin was expressed by tumor cells in 11/45 (24%) cases of LyP, 11/17 (64%) cases of ALCL, 7/9 (77%) cases of PTL and 6/10 (60%) cases of LyP associated with systemic lymphomas. Fascin expression in LyP was significantly less frequent than in ALCL (p < 0.001) and also than in LyP associated with lymphomas (p < 0.05). There was no significant difference of fascin expression within the histological subtypes of LyP. We found no evidence of ALK expression nor of Epstein–Barr virus expression in any case either by in situ hybridization or immunohistochemistry in the LyP cases associated with HL. Conclusions: This is the first study to demonstrate that fascin is expressed in cutaneous CD30+ LPD and that it is a candidate marker of disease progression in LyP.Keywords
This publication has 18 references indexed in Scilit:
- Absence of anaplastic lymphoma kinase (ALK) and Epstein-Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosisBritish Journal of Dermatology, 1997
- The Same Dominant T Cell Clone Is Present in Multiple Regressing Skin Lesions and Associated T Cell Lymphomas of Patients with Lymphomatoid PapulosisJournal of Investigative Dermatology, 1996
- Lymphomatoid Papulosis and Associated Cutaneous Lymphoproliferative Disorders Exhibit a Common Clonal OriginJournal of Investigative Dermatology, 1995
- Absence of Epstein—Barr viral RNA in lymphomatoid papulosisThe Journal of Pathology, 1993
- Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disordersJournal of the American Academy of Dermatology, 1993
- Hodgkin's Disease, Lymphomatoid Papulosis, and Cutaneous T-Cell Lymphoma Derived from a Common T-Cell CloneNew England Journal of Medicine, 1992
- Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's diseaseThe Lancet, 1991
- Hodgkin's disease followed by lymphomatoid papulosisJournal of the American Academy of Dermatology, 1990
- Atypical Cells in Lymphomatoid Papulosis Express the Hodgkin Cell-Associated Antigen Ki-1Journal of Investigative Dermatology, 1986
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984